(1)
Efficacy and Survival Analysis of Apatinib Combined With Capecitabine Chemotherapy for Second-Line Treatment of Advanced Esophageal Cancer. IJCT 2023, 29 (6), 793-798. https://doi.org/10.56042/ijct.v29i6.67385.